Understanding the lung cancer mortality reductions produced by low-dose CT screening-Authors' reply
Stephen W Duffy1, John K Field2
1Centre for Prevention, Detection and Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
The Lancet Regional Health. Europe
|December 24, 2021
Abstract
No abstract available in PubMed .
More Related Videos
07:53Author Spotlight: Advancing 3D Modeling for Enhanced Diagnosis and Treatment of Pulmonary Nodules in Early-Stage Lung Cancer
Published on: October 13, 2023
1.6K
08:14MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
15.8K
